Michela Tinelli

Michela Tinelli

Auto-generated profile, based on publicly available information

Michela Tinelli

Care Policy and Evaluation Centre , London School of Economics and Political Science , London , UK , lse.ac.uk

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
JCJoao Jose Cerqueira
Joao Jose Cerqueira
DCD Alastair S Compston
D Alastair S Compston
RGRuth Geraldes
Ruth Geraldes
MRMario M Rosa
Mario M Rosa
KSKlaus Schmierer
Klaus Schmierer
JPJacqueline Palace
Jacqueline Palace
The management of multiple sclerosis (MS) has been a neurology success story for the past 25 years. Advances in understanding of the disease mechanisms and the dynamic nature of the disease have brought around 12 disease-modifying therapies (DMTs) to market in many countries.

24 April 2017 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AMAndrea Manfrin
Andrea Manfrin
MTMichela Tinelli
Michela Tinelli
TTTrudy Thomas
Trudy Thomas
JKJanet Krska
Janet Krska
The economic burden of asthma, which relates to the degree of control, is €5 billion annually in Italy. Pharmacists could help improve asthma control, reducing this burden. This study aimed to evaluate the effectiveness and cost-effectiveness of Medicines Use Reviews provided by community pharmacists in asthma. This cluster randomised, multi-centre, controlled trial in adult patients with asthma was conducted in 15 of the 20 regions of Italy between September 2014 and July 2015. After stratification by region, community pharmacists were randomly allocated to group A (trained in and delivered the intervention at baseline) or B (training and delivery 3 months later), using computerised random number generation in blocks of 10. Each recruited up to five patients, with both groups followed for 9 months. The intervention consisted of a systematic, structured face-to-face consultation with a pharmacist, covering asthma symptoms, medicines used, attitude towards medicines and adherence, recording pharmacist-identified pharmaceutical care issues (PCIs). The primary outcome was asthma control, assessed using the Asthma-Control-Test (ACT) score (ACT ≥ 20 represents good control). Secondary outcomes were: number of active ingredients, adherence, cost-effectiveness compared with usual care. Although blinding was not possible for either pharmacists or patients, assessment of outcomes was conducted by researchers blind to group allocation. Numbers of pharmacists and patients enrolled were 283 (A = 136; B = 147) and 1263 (A = 600; B = 663), numbers completing were 201 (A = 97; B = 104) and 816 (A = 400; B = 416), respectively. Patients were similar in age and gender and 56.13% (458/816) had poor/partial asthma control. Pharmacists identified 1256 PCIs (mean 1.54/patient), mostly need for education, monitoring and potentially ineffective therapy. Median ACT score at baseline differed between groups (A = 19, B = 18; p < 0.01). Odds ratio for improved asthma control was 1.76 (95% CI 1.33–2.33) and number needed to treat 10 (95% CI 6–28). Number of active ingredients reduced by 7.9% post-intervention (p < 0.01). Adherence improved by 35.4% 3 months post-intervention and 40.0% at 6 months (p < 0.01). The probability of the intervention being more cost-effective than usual care was 100% at 9 months. This community pharmacist-based intervention demonstrated both effectiveness and cost-effectiveness. It has since been implemented as the first community pharmacy cognitive service in Italy. TRN: ISRCTN72438848 (registered 5th January 2015, retrospectively).

1 December 2007 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
MTMichela Tinelli
Michela Tinelli
CBChristine Bond
Christine Bond
ABAlison Blenkinsopp
Alison Blenkinsopp
MJMariesha Jaffray
Mariesha Jaffray
MWMargaret Watson
Margaret Watson
PHPhilip Hannaford
Philip Hannaford
Background: A patient-centered approach is increasingly recognized as an important component in the evaluation of healthcare services. Objective: To assess patient satisfaction with, attitudes toward, and expectations of or experience with community pharmacy in genera), and to evaluate the effect of the community pharmacy–led medications management service on these factors. Methods: Postal questionnaire surveys were completed at baseline and after 12 months (follow-up) as part of a randomized controlled trial of the service. The setting was 9 primary care organizations in England. Patients with coronary heart disease were recruited from general practice registers and randomly allocated to the intervention (pharmacy-led medications management service) or control group. Results: Survey response rates at baseline and follow-up were 88.4% (1232/1394) and 80.1% (1085/1355), respectively. The respondents indicated that they wanted pharmacists to provide dispensing, medications review, advice on medications and health, private consultation areas, and short visit times. At follow-up, intervention patients were more likely than control patients (p < 0.01) to rate the service provided by their pharmacist with a higher level of satisfaction, and most intervention patients stated a preference for seeing their physician to discuss their medications, although this was less marked than in control patients (76% vs 85%; p < 0.01). Intervention patients were also more willing than control patients to ask the pharmacist questions that they would be unable to ask a physician (20% vs 11%, respectively; p < 0.01), to ask the pharmacist questions about their medications (32% vs 18%, respectively; p < 0.01), and to recommend this practice to others (51% vs 40%, respectively; p < 0.01). Conclusions: Pharmacist intervention was associated with significant and positive changes in patient satisfaction. While patients probably continue to prefer a physician-led service, they value aspects of a pharmacy service. Patients generally preferred discussing medications with the family physician, but experiencing the community pharmacy-led service resulted in an attitudinal shift toward the pharmacist. These findings suggest a benefit in developing the community pharmacist's role as a reviewer of, and adviser on, patients' medications.

1 July 2012 in Value in Health
Verified
Journal Article
Closed access
KGKaren Gerard
Karen Gerard
MTMichela Tinelli
Michela Tinelli
SLSue Latter
Sue Latter
ABAlison Blenkinsopp
Alison Blenkinsopp
ASAlesha Smith
Alesha Smith

1 December 2007 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
CMCatriona Matheson
Catriona Matheson
CBChristine M. Bond
Christine M. Bond
MTMichela Tinelli
Michela Tinelli
Background Community pharmacy contributes to drug misuse management and reduced spread of blood-borne disease through distributing clean needles and substitute drug dispensing. This paper reports a third Scotland-wide survey of pharmacies enabling service delivery to be charted over a decade.

1 April 2014 in Patient Education and Counseling
Verified
Journal Article
Closed access
EWEmily Warren
Emily Warren
KFKatharine Footman
Katharine Footman
MTMichela Tinelli
Michela Tinelli
MMMartin McKee
Martin McKee
CKCecile Knai
Cecile Knai